Generic drug repurposing is an underused but promising tool for finding new, affordable therapies. Creating a pull incentive ...

With all AI related to New Product Development & Marketing, it’s early days full of experimentation & important learnings.

In conventional drug development ... points of failure in the manufacturing process, allowing QA teams to address issues before they affect product quality. Moreover, ML algorithms can be trained ...

March-in rights are vital safeguards that allow the federal government to license competitors when the owner is not making a ...

In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.

Clinical trials for drug development are becoming increasingly complex, with numerous variables that must be identified and defined from the start. This complexity arises from rigorous study ...

Global Biosimilars Week discussed issues in biosimilar adoption and called for reforms to streamline processes, foster ...

Automation, particularly in the form of robots, can be applied to discrete processes such as placing an active ingredient ...

Kirin is stepping up investment in pharmaceutical, health food, and cosmetics businesses due to secular volume decline in the domestic beer market. Management has completed the divestiture process of ...

The European Medicines Agency (EMA) could table proposals next year to relax requirements around the need for comparative ...

President-elect Donald Trump has vowed to impose massive tariffs on China, Canada and Mexico with the aim of stopping drug ...